← Open Payments lookup

VIVEKANANDA RACHAMALLU: Open Payments

NPI 1942687470 · ERLANGER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$458 in 23 payments from 8 companies in 2025. Trend: 2023 $276 · 2024 $600 · 2025 $458

Food & beverage: $458
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.6$116
Teva Pharmaceuticals USA, Inc.5$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$68
Luye Pharma (USA) Ltd.3$59
Noven Therapeutics, LLC2$42
ABBVIE INC.1$32
Indivior Inc.1$25
Neurocrine BioSciences, Inc.1$18

Products named: AUSTEDO XR, ABILIFY MAINTENA, CAPLYTA, ERZOFRI EXTENDED-RELEASE, VRAYLAR, SUBLOCADE, ABILIFY ASIMTUFII, Xelstrym.

Industry payments across KY — which companies pay providers there.